Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Nucala
Nucala
AstraZeneca, working to grow Fasenra’s reach, touts positive trial against GSK's Nucala in new use
Fierce Pharma
Tue, 09/12/23 - 07:10 pm
AstraZeneca
Fasenra
clinical trials
GSK
Nucala
eosinophilic asthma
AstraZeneca’s Fasenra meets primary endpoint in Phase III rare vasculitis trial
Clinical Trials Arena
Tue, 09/12/23 - 10:37 am
AstraZeneca
Fasenra
GSK
Nucala
eosinophilic granulomatosis with polyangiitis
clinical trials
GSK looks to stand out in the severe asthma space with at-home injections for kids 6 to 11 years old
Endpoints
Mon, 01/24/22 - 11:34 pm
GSK
Nucala
pediatric
severe asthma
GlaxoSmithKline's Nucala beats AZ's Fasenra to the IL-5 punch in nasal polyps
Fierce Pharma
Thu, 07/29/21 - 11:04 pm
GSK
Nucala
nasal polyps
FDA
GlaxoSmithKline's Nucala targets rival AstraZeneca with FDA nod for rare white blood cell disease
Fierce Pharma
Mon, 09/28/20 - 10:37 am
GSK
Nucala
hypereosinophilic syndrome
FDA
AstraZeneca
GSK's national TV push for Nucala gives another meaning to 'new normal'
Fierce Pharma
Mon, 07/13/20 - 11:10 am
GSK
Nucala
asthma
television ads
DTC ads
GSK's asthma drug Nucala gets speedy review for rare blood disorder
Endpoints
Wed, 05/27/20 - 10:25 am
GSK
FDA
Nucala
hypereosinophilic syndrome
HES
priority review
GSK's asthma biologic Nucala is one step closer to approval in key chronic rhinosinusitis population
Endpoints
Fri, 04/3/20 - 11:12 am
GSK
Nucala
rhinosinusitis
nasal polyps
clinical trials
Nucala works in rare inflammatory disease, says GSK
PM Live
Wed, 11/13/19 - 09:55 am
GSK
clinical trials
Nucala
hypereosinophilic syndromes
HES
GlaxoSmithKline's Nucala cuts severe asthma attacks in 'reassuring' interim real-world data
Fierce Pharma
Tue, 10/1/19 - 10:05 am
GSK
Nucala
severe asthma
real world data
Glaxo's Asthma Drug Nucala Gets FDA Nod for Pediatric Use
Yahoo/Zacks.com
Fri, 09/13/19 - 10:59 am
GSK
Nucala
eosinophilic asthma
pediatrics
FDA
GlaxoSmithKline's Nucala scores convenience boost with at-home dosing options
Fierce Pharma
Fri, 06/7/19 - 10:07 am
GSK
FDA
Nucala
autoinjectors
eosinophilic asthma
GSK seeks pediatric indication for Nucala in severe eosinophilic asthma
Pharmaceutical Business Review
Tue, 11/20/18 - 08:27 pm
GSK
Nucala
pediatric
eosinophilic asthma
GSK touts Nucala data after COPD miss
Biopharma Dive
Tue, 09/11/18 - 11:55 am
GSK
asthma
COPD
Nucala
The pain won’t stop. GSK ends the week with a slapdown on its Nucala application for COPD
Endpoints
Fri, 09/7/18 - 06:34 pm
GSK
Nucala
FDA
complete response letter
COPD
EC approves GSK's Nucala for kids with severe asthma
Biopharma Dive
Fri, 08/31/18 - 11:51 pm
GSK
Nucala
Europe
asthma
FDA staff raises efficacy doubts on GSK's lung disease treatment
Yahoo/Reuters
Mon, 07/23/18 - 09:38 am
GSK
FDA
Nucala
COPD
NICE says yes to AstraZeneca’s Fasenra, but only when its GSK rival can’t be used
Fierce Pharma
Sun, 07/22/18 - 12:21 pm
AstraZeneca
Fasenra
GSK
Nucala
NICE
asthma
Glaxo aims to lure patients from Novartis' Xolair with Nucala switching study
Fierce Pharma
Tue, 03/6/18 - 09:27 am
GSK
Novartis
Xolair
Nucala
asthma
GlaxoSmithKline, now vying with AstraZeneca, scores brand-new market for Nucala
Fierce Pharma
Wed, 12/13/17 - 11:07 am
GSK
AstraZeneca
Nucala
eosinophilic granulomatosis with polyangiitis
Pages
1
2
next ›
last »